New drug shows promise for diabetes and weight loss
NCT ID NCT05110846
Summary
This study tested an investigational drug called CT-868 to see if it could help lower blood sugar and reduce body weight in adults with type 2 diabetes who are also overweight or obese. Over 100 participants received either the drug or a placebo for 26 weeks. The main goal was to see how well the drug controlled long-term blood sugar levels and whether it was safe and tolerable.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Carmot Clinical Center MX01
Monterrey, Nuevo León, Mexico
-
Carmot Clinical Center MX02
Monterrey, Nuevo León, Mexico
-
Carmot Clinical Center MX03
Mexico City, Mexico
-
Carmot Clinical Center MX04
Guadalajara, Jalisco, Mexico
-
Carmot Clinical Center MX05
Mérida, Yucatán, Mexico
Conditions
Explore the condition pages connected to this study.